1. Contact address(Person who provides information. This information will be treated confidentially)?

Title: MD

First Name: Perry

Last Name: Iloegbunam

State: Nigeria

Country: Africa

Institution: Stem Cell Transplantation Project for Africa and BIO-CELLULAR RESEARCH ORGANIZATION LLC

Telephone:

Email:

2. What is the source of your information about human xenotransplantation practices?

• http://fdanews.com/newsletter/article?issuId=10799&articleId=99193
• http://stem-cell-transplantation.com

3. What is the therapeutic purpose of this xenotransplantation treatment?

Diabetes

Down syndrome

4. Where and when is this human xenotransplantation practice taking place?

Country: Nigeria

Timing: In progress

5. Is this treatment part of a clinical trial?

No

6. What is the animal source of the xenotransplantation product?

Rabbit, Pig

7.Source Animals

Do you have information about source animals?

No

8. Testing of safety

Do you have information about testing of safety?

No

9. What type of cells/tissues/organs was transplanted?

Cells:

Tissues:

Organs:

Others: Stem cells

10.What type of exposure to xenogeneic cells was involved?

• Solid-organ Xenotransplantation: No
• Cellular Xenotransplantation: Yes
• Tissue Xenotransplantation: No
• Human cells exposed to xenogeneic Feeder cells: No
• Extracorporeal perfusion: No
• Encapsulation: No
• Other bioartificial isolation device:
• Others:

11. Do you have information about transplant recipients?

No

12. Have results been presented at a scientific congress?

Unknown

if yes, where?

13. Have results been published in a scientific journal?

Unknown

if yes, Where?

14. Is this human clinical trial performed with governmental and/or institutional oversight and supervision?

Unknown

If yes, which?

15. Comment

BIO-CELLULAR RESEARCH ORGANIZATION LLC. The office is registered in Newark, USA. For more information, we can read these different websites:

1)http://stem-cell-transplantation.com/contact.html

2)http://stem-cell-transplantation.com/about_us.html